Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease

Objective: To improve diagnostic criteria for sporadic Creutzfeldt–Jakob disease (CJD). Methods: Pooled data on initial and final diagnostic classification of suspected CJD patients were accumulated, including results of investigations derived from a coordinated multinational study of CJD. Prospective analysis for a comparison of clinical and neuropathologic diagnoses and evaluation of the sensitivity and specificity of EEG and 14-3-3 CSF immunoassay were conducted. Results: Data on 1,003 patients with suspected CJD were collected using a standard questionnaire. After follow-up was carried out, complete clinical data and neuropathologic diagnoses were available in 805 cases. In these patients, the sensitivity of the detection of periodic sharp wave complexes in the EEG was 66%, with a specificity of 74%. The detection of 14-3-3 proteins in the CSF correlated with the clinical diagnosis in 94% (sensitivity). The specificity (84%) was higher than that of EEG. A combination of both investigations further increased the sensitivity but decreased the specificity. Conclusions: Incorporation of CSF 14-3-3 analysis in the diagnostic criteria for CJD significantly increases the sensitivity of case definition. Amended diagnostic criteria for CJD are proposed.

[1]  O. Gefeller,et al.  S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease , 1997, Journal of Neurology.

[2]  K. Jellinger,et al.  Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.

[3]  O. Gefeller,et al.  Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[4]  S. DeArmond,et al.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. , 1996, Archives of neurology.

[5]  P. Brown,et al.  Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.

[6]  I. Zerr,et al.  MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.

[7]  J. Laplanche,et al.  14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[8]  H. Kretzschmar,et al.  Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease , 1995, The Lancet.

[9]  J. Collinge,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[10]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[11]  DavidJ. Evans,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[12]  K. Kato,et al.  High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[13]  A. Hofman,et al.  Descriptive epidemiology of Creutzfeldt‐Jakob disease in six european countries, 1993–1995 , 1998, Annals of neurology.

[14]  Z. Meiner,et al.  Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease , 1997, Neurology.

[15]  P. Cortelli,et al.  Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. , 1986, The New England journal of medicine.

[16]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.

[17]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[18]  B. Steinhoff,et al.  Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. , 1996, Archives of neurology.

[19]  J. Finsterer,et al.  Hypothyroid Myopathy with Unusually High Serum Creatine Kinase Values , 2000, Hormone Research in Paediatrics.

[20]  M. Zeidler,et al.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests , 1997, The Lancet.

[21]  P. Brown,et al.  Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease , 1996, The Lancet.

[22]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[23]  J. Ruhlmann,et al.  18F-fluorodeoxyglucose-PET and99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease , 1996, Annals of nuclear medicine.